BIOLASE Announces Pricing of $6.5 Million Registered Direct Offering Priced At-the-Market

LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $6.5 million of its common stock and…